BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Zheng-Jie Xu, Jun-Ping Shi, De-Rong Yu, Li-Juan Zhu, Ji-Dong Jia, Jian-Gao Fan. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study DesignAdvances in Therapy 2016; 33(11): 2069 doi: 10.1007/s12325-016-0416-4
2
Non-alcoholic Fatty Liver Disease: A Clinical UpdateJournal of Clinical and Translational Hepatology  doi: 10.14218/JCTH.2017.00013
3
Szkup Małgorzata, Brodowski Jacek, Owczarek Aleksander Jerzy, Choręza Piotr, Jurczak Anna, Grochans Elżbieta. Searching for Factors Raising the Incidence of Metabolic Syndrome Among 45-60-Year-Old WomenAging and disease 2018; 9(5): 831 doi: 10.14336/AD.2017.1027
4
Teruki Miyake, Yoichi Hiasa. The Evolving Landscape of Liver Cirrhosis Management2019; : 1 doi: 10.1007/978-981-13-7979-6_1
5
Ann P. Walker. Ischaemic stroke and liver fibrosisAtherosclerosis 2017; 260: 153 doi: 10.1016/j.atherosclerosis.2017.03.028
6
Ali Saeed, Robin Dullaart, Tim Schreuder, Hans Blokzijl, Klaas Faber. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)Nutrients 2017; 10(1): 29 doi: 10.3390/nu10010029
7
Daniel F. Mazo, Fernanda M. Malta, Jose Tadeu Stefano, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Jazon R. Almeida, Joao Renato R. Pinho, Flair J. Carrilho, Claudia P. Oliveira. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed populationAnnals of Hepatology 2019; 18(3): 466 doi: 10.1016/j.aohep.2018.10.004
8
T. Herta, J. Fischer, T. Berg. Genetik metabolischer und viraler LebererkrankungenDer Gastroenterologe 2017; 12(1): 16 doi: 10.1007/s11377-016-0128-y
9
Ligiane Marques Loureiro, Suzane Lessa, Rodrigo Mendes, Sílvia Pereira, Carlos José Saboya, Andrea Ramalho. Does the Metabolically Healthy Obese Phenotype Protect Adults with Class III Obesity from Biochemical Alterations Related to Bone Metabolism?Nutrients 2019; 11(9): 2125 doi: 10.3390/nu11092125
10
Charlotte J. Green, Siôn A. Parry, Pippa J. Gunn, Carlo D.L. Ceresa, Fredrik Rosqvist, Marie-Eve Piché, Leanne Hodson. Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human modelsHormone Molecular Biology and Clinical Investigation 2018; 0(0) doi: 10.1515/hmbci-2018-0038
11
V. Nathan Subramaniam. Ironing out SteatohepatitisAnnals of Hepatology 2017; 16(1): 8 doi: 10.5604/16652681.1226809
12
Chaonan Xu, Zhimin Ma, Yunfeng Wang, Xiangtong Liu, Lixin Tao, Deqiang Zheng, Xiuhua Guo, Xinghua Yang. Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-upLiver International 2018; 38(12): 2294 doi: 10.1111/liv.13941
13
Anna L. Lang, Juliane I. Beier. Interaction of volatile organic compounds and underlying liver disease: a new paradigm for riskBiological Chemistry 2018; 399(11): 1237 doi: 10.1515/hsz-2017-0324
14
Giulia Bellini, Emanuele Miraglia del Giudice, Valerio Nobili, Francesca Rossi. The IRGM rs10065172 variant increases the risk for steatosis but not for liver damage progression in Italian obese childrenJournal of Hepatology 2017; 67(3): 653 doi: 10.1016/j.jhep.2017.02.037
15
Herbert L. Bonkovsky, Tyler Severson, Paola Nicoletti, Huiman Barnhart, Jose Serrano, Naga Chalasani, Robert J. Fontana, Paul B. Watkins, Victor Navarro, Andrew Stolz, Ann K. Daly, Guruparasad P. Aithal, Joseph Odin. Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug‐Induced Liver InjuryHepatology Communications 2019; 3(8): 1032 doi: 10.1002/hep4.1382
16
Sarah E. Kleinstein, Matthew Rein, Manal F. Abdelmalek, Cynthia D. Guy, David B. Goldstein, Anna Mae Diehl, Cynthia A. Moylan. Whole‐Exome Sequencing Study of Extreme Phenotypes of NAFLDHepatology Communications 2018; 2(9): 1021 doi: 10.1002/hep4.1227
17
Leanne Hodson, Pippa J. Gunn. The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional stateNature Reviews Endocrinology 2019; 15(12): 689 doi: 10.1038/s41574-019-0256-9
18
Kuniko Yamamoto, Tomomi Kogiso, Makiko Taniai, Etsuko Hashimoto, Katsutoshi Tokushige. Differences in the genetic backgrounds of patients with alcoholic liver disease and non-alcoholic fatty liver diseaseJGH Open 2019; 3(1): 17 doi: 10.1002/jgh3.12097
19
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, Alessandra Marrazzo, Luca Rinaldi, Luigi Elio Adinolfi. Nonalcoholic fatty liver disease: Evolving paradigmsWorld Journal of Gastroenterology 2017; 23(36): 6571-6592 doi: 10.3748/wjg.v23.i36.6571
20
Ruth Schübel, Tobias Nonnenmacher, Disorn Sookthai, Sandra Gonzalez Maldonado, Solomon Sowah, Oyunbileg von Stackelberg, Christopher Schlett, Mirja Grafetstätter, Diana Nabers, Theron Johnson, Romy Kirsten, Cornelia Ulrich, Rudolf Kaaks, Hans-Ulrich Kauczor, Tilman Kühn, Johanna Nattenmüller. Similar Weight Loss Induces Greater Improvements in Insulin Sensitivity and Liver Function among Individuals with NAFLD Compared to Individuals without NAFLDNutrients 2019; 11(3): 544 doi: 10.3390/nu11030544
21
Fernando Bessone, María Valeria Razori, Marcelo G. Roma. Molecular pathways of nonalcoholic fatty liver disease development and progressionCellular and Molecular Life Sciences 2019; 76(1): 99 doi: 10.1007/s00018-018-2947-0
22
Ludovico Abenavoli, Natasa Milic, Francesco Luzza, Luigi Boccuto, Antonino De Lorenzo. Polyphenols treatment in patients with nonalcoholic fatty liver diseaseJournal of Translational Internal Medicine 2017; 5(3): 144 doi: 10.1515/jtim-2017-0027
23
Christopher J. Schmoyer, Mohammad S. Siddiqui. Non-alcoholic Fatty Liver Disease in Non-obese PatientsCurrent Hepatology Reports 2017; 16(4): 382 doi: 10.1007/s11901-017-0377-3
24
Miaomiao Yang, Haiping Zhang, Bilin Tao, Hongqiu Pan, Lihuan Lu, Honggang Yi, Shaowen Tang. Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control studyJournal of Clinical Pharmacy and Therapeutics 2019; 44(4): 534 doi: 10.1111/jcpt.12818
25
Qun Liu, Shou-Sheng Liu, Zhen-Zhen Zhao, Ben-Tian Zhao, Shui-Xian Du, Wen-Wen Jin, Yong-Ning Xin. TRIB1 rs17321515 gene polymorphism increases the risk of coronary heart disease in general population and non-alcoholic fatty liver disease patients in Chinese Han populationLipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1108-2
26
Rohini Mehta, Kianoush Jeiran, Aaron B. Koenig, Munkzhul Otgonsuren, Zachary Goodman, Ancha Baranova, Zobair Younossi. The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)BMC Medical Genetics 2016; 17(1) doi: 10.1186/s12881-016-0324-0
27
Dan L. Longo, Anna M. Diehl, Christopher Day. Cause, Pathogenesis, and Treatment of Nonalcoholic SteatohepatitisNew England Journal of Medicine 2017; 377(21): 2063 doi: 10.1056/NEJMra1503519
28
Giuseppina R Umano, Sonia Caprio, Anna Di Sessa, Naga Chalasani, Daniel J Dykas, Bridget Pierpont, Allen E Bale, Nicola Santoro. The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese YouthAmerican Journal of Gastroenterology 2018; 113(3): 376 doi: 10.1038/ajg.2018.1